Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals

References

• Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14
   PubMed Web of Science ®Google Scholar
• Zhang P, Zhang X, Brown J, et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:293-301
   PubMed Web of Science ®Google Scholar
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-86
   PubMed Web of Science ®Google Scholar
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53
   PubMed Web of Science ®Google Scholar
• Coscelli C, Lostia S, Lunetta M, et al. Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract 1995;28:173-7
   PubMed Web of Science ®Google Scholar
• Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila) 2004;43:69-74
   PubMed Web of Science ®Google Scholar
• Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 1999;22:137-40
   PubMed Web of Science ®Google Scholar
• Glasgow RE, Fisher EB, Anderson BJ, et al. Behavioral science in diabetes. Contributions and opportunities. Diabetes Care 1999;22:832-43
   PubMed Web of Science ®Google Scholar
• Peyrot M, Rubin RR, Lauritzen T, et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005;28:2673-9
   PubMed Web of Science ®Google Scholar
• Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;26:1498-505
   PubMed Web of Science ®Google Scholar
• Thurman JE. Insulin pen injection devices for management of patients with type 2 diabetes: considerations based on an endocrinologist's practical experience in the United States. Endocr Pract 2007;13:672-8
   PubMedGoogle Scholar
• Sommavilla B, Jorgensen C, Jensen KH. Safety, simplicity and convenience of a modified prefilled insulin pen. Expert Opin Pharmacother 2008;9:2223-32
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27:2495-7
   PubMed Web of Science ®Google Scholar
• Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance. Diabetes Care 1997;20:292-8
   PubMed Web of Science ®Google Scholar
• Karter AJ, Subramanian U, Saha C, et al. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care 2010;33:733-5
   PubMed Web of Science ®Google Scholar
• Mollema ED, Snoek FJ, Heine RJ, et al. Phobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screening. Diabet Med 2001;18:671-4
   PubMed Web of Science ®Google Scholar
• Peyrot M, Mathews DR, Snoek FJ, et al. An international study of psychological resistance to insulin use among persons with diabetes. Diabetologia 2003;46(Suppl 2):A89
   PubMed Web of Science ®Google Scholar
• Zambanini A, Newson RB, Maisey M, et al. Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract 1999;46:239-46
   PubMed Web of Science ®Google Scholar
• Brunton S. Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment. Am J Med 2008;121:S35-41
   PubMed Web of Science ®Google Scholar
• Olsen BS, Lilleøre SK, Korsholm CN, et al. NovoPen Echo for the delivery of insulin: a comparison of usability, functionality and preference among pediatric subjects, their parents and health care professionals. J Diabetes Sci Tech 2010;4:1468-75
   PubMedGoogle Scholar
• Pfützner J, Hellhammer J, Musholt P, et al. Evaluation of dexterity in insulin-treated patients with type 1 and type 2 diabetes mellitus. J Diabetes Sci Technol 2011;5:158-65
   PubMedGoogle Scholar
• Asakura T, Jensen KH. Comparison of intuitiveness, ease of use, and preference in two insulin pens. J Diabetes Sci Technol 2009;3:312-19
   PubMedGoogle Scholar
• Pearson TL. Practical aspects of insulin pen devices. J Diabetes Sci Technol 2010;4:522-31
   PubMedGoogle Scholar
• Bastian MD, Wolters NE, Bright DR. Insulin pens vs. vials and syringes: differences in clinical and economic outcomes. Consult Pharm 2011;26:426-9
   PubMedGoogle Scholar
• Hemmingsen H, Niemeyer M, Hansen MR, et al. A prefilled insulin pen with a novel injection mechanism and a lower injection force than other prefilled insulin pens. Diabetes Technol Ther 2011; doi: 10.1089/dia.2011.0110. [Epub ahead of print]
   Google Scholar
• Pfützner A, Reimer T, Frokjaer LPF, et al. Prefilled insulin device with reduced injection force: patient perception and accuracy. Curr Med Res Opin 2008;24:2545-9
   PubMed Web of Science ®Google Scholar
• Savas¸ S, Köroğlu BK, Koyuncuoğlu HR, et al. The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients. Diabetes Res Clin Pract 2007;77:77-83
   PubMed Web of Science ®Google Scholar
• Schady W, Abuaisha B, Boulton AJ. Observations on severe ulnar neuropathy in diabetes. J Diabetes Complications 1998;12:128-32
   PubMed Web of Science ®Google Scholar
• Ziegler D, Gries FA, Spuler M, et al. The epidemiology of diabetic neuropathy. DiaCAN Multicenter Study Group. Diabet Med 1993;10(Suppl 2):82S-6S
   PubMedGoogle Scholar
• Wielandt JO, Niemeyer M, Hansen MR, et al. FlexTouch®: a prefilled insulin pen with a novel injection mechanism with consistent, high accuracy at low (1 IU), medium (40 IU) and high (80 IU) dose settings. J Diabetes Sci Tech 2011;5:1195-9
   Google Scholar
• Peyrot M, Rubin RR. Factors associated with persistence and resumption of insulin pen use for patients with type 2 diabetes. Diabetes Tech Therapeut 2011;13:43-8
   PubMed Web of Science ®Google Scholar
• Rubin RR, Peyrot M. Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care 2008;31:430-2
   PubMed Web of Science ®Google Scholar
• Faurie C, Raymond M. Handedness frequency over more than ten thousand years. Proc Biol Sci 2004;271(Suppl 3):S43-5
   PubMed Web of Science ®Google Scholar
• Buus P, Lilleøre SK, Larsen K. Compatibility testing of two types of pen needles with a range of injection pens for diabetes medication. Curr Med Res Opin 2011;27:589-92
   PubMed Web of Science ®Google Scholar
• Niskanen L, Jensen LE, Rastam J, et al. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus. Clin Ther 2004;26:531-40
   PubMed Web of Science ®Google Scholar
• Wilcoxon F. Individual comparisons by ranking methods. Biometrics Bulletin 1945;1:80-3
   Google Scholar
• McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 1947;12:153-7
   PubMed Web of Science ®Google Scholar
• Brod M, Kongso JH, Lessard S, et al. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res 2009;18:23-32
   PubMed Web of Science ®Google Scholar
• Clark PE, Valentine V, Bodie JN, et al. Ease of use and patient preference injection simulation study comparing two prefilled insulin pens. Curr Med Res Opin 2010;26:1745-53
   PubMed Web of Science ®Google Scholar
• Musholt P, Schipper C, Niemeyer M, et al. Self-assessment and determination of dexterity and cognitive function in patients with type 1 and type 2 diabetes mellitus [abstract] No 2222-PO. American Diabetes Association 71st Scientific Sessions. Diabetes 2011;60(Suppl 1)
   Google Scholar